Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)
2017 · European Urology · 106 citations
https://doi.org/10.1016/j.eururo.2017.08.012